Grikzone-S Injection
123,00 ₹
Analogs of Grikzone-S Injection
Find cheaper analogs and generic equivalents for Grikzone-S Injection.
Princípio ativo: Ceftriaxone; Sulbactam
Visão geral do produto
About Grikzone-S Injection
Grikzone-S Injection is a medication containing the active ingredient Ceftriaxone, classified as Antibiotic medication. Ceftriaxone, sold under the brand name Rocephin, is a third-generation cephalosporin antibiotic used for the treatment of a number of bacterial infections. These include middle ear infections, endocarditis, meningitis, pneumonia, bone and joint infections, intra-abdominal infections, skin infections, urinary tract inf….
Key Benefits & Uses
- Used for: INDICATIONS AND USAGE Before instituting treatment with ceftriaxone, appropriate specimens should be obtained for isolation of the causative organism.
- Used for: Therapy may be instituted prior to obtaining results of susceptibility testing
- Use only as directed on the product label or by a healthcare professional.
Active Ingredient & Action
Ceftriaxone, the active ingredient in Grikzone-S Injection, belongs to the Antibiotic medication class. INDICATIONS AND USAGE Before instituting treatment with ceftriaxone, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing. Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking Grikzone-S Injection. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Grikzone-S Injection for extended periods without medical advice.
Find in Pharmacies
Compare local prices and distance for Grikzone-S Injection.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.